M

Marker Therapeutics, Inc.

57 employees

Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Therapeutics
Immunotherapy and T Cell Based Therapies

Date founded

2018

Funding rounds raised

Total raised

$25M

from 3 investors over 3 rounds

M

Marker Therapeutics, Inc. raised $2M on June 26, 2023

Investors: National Institutes of Health

M

Marker Therapeutics, Inc. raised $25M on December 13, 2022

Investors: Lincoln Park Capital, LLC

M

Marker Therapeutics, Inc. raised $13M on August 19, 2021

Investors: Cancer Prevention and Research Institute of Texas

FAQ